Related Experiment Video
Updated: Aug 29, 2026

08:12
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Tumor markers and colorectal cancer: utility in management
Nigel P S Crawford1, Daniel W Colliver, Susan Galandiuk
1Price Institute of Surgical Research, Department of Surgery, University of Louisville, Kentucky 40292, USA.
Journal of Surgical Oncology
|February 6, 2004
Abstract:
Colorectal cancer (CRC) is a leading cause of morbidity and mortality. Although genetic testing can screen for rare hereditary CRC syndromes, there is no ideal means of screening for sporadic forms of CRC. This review will focus on markers that are currently used in the management of sporadic CRC and their limitations, as well as possible future clinical applications.
